NPK International Inc. (NPKI)
Official siteINDUSTRIALS • OIL & GAS EQUIPMENT & SERVICES • NYSE
Market Cap: $757.83M
Last updated: Nov 17, 2026 at 11:05 AM ET
NPK International Inc. (NPKI) Stock Forecast
Analysts expect NPK International (NPKI) to earn $0.49 per share in the fiscal year ending Dec 31, 2026, on revenue of $302.30M. Of 3 analysts, 3 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 3 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 3 | 100.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 24.5% and revenue estimates rise 13.7%.
- Fiscal year ending Dec 31, 2026
- $0.49
- EPS consensus, revenue $302.30M
- Fiscal year ending Dec 31, 2027
- $0.61
- EPS consensus, revenue $343.75M
- Next report
- Feb 23, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.49 | $0.47 to $0.50 | 3 | $302.30M | $301.00M to $303.90M | 3 |
| Dec 31, 2027 | $0.61 | $0.58 to $0.65 | 3 | $343.75M | $341.00M to $348.96M | 3 |
Quarterly Estimates
The EPS consensus is $0.13 for both quarters below, ending Dec 31, 2026 and Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.13 | $0.11 to $0.17 | 6 | $71.33M | $66.71M to $75.14M | 6 |
| Mar 31, 2027 | $0.13 | $0.13 to $0.13 | 1 | $77.60M | $77.60M to $77.60M | 1 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 4 upward and 3 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 3 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 2 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 10.9% from $0.55.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.49 | $0.55 | $0.55 | $0.55 | $0.55 | -11.5% |
| Fiscal year ending Dec 31, 2027 | $0.61 | $0.63 | $0.63 | $0.63 | $0.63 | -2.1% |
| Quarter ending Mar 31, 2027 | $0.13 | $0.14 | $0.14 | $0.14 | $0.14 | -7.1% |
Frequently Asked Questions About NPKI
What is the NPKI stock forecast?
Consensus analyst estimates put NPK International's EPS at $0.49 for the fiscal year ending Dec 31, 2026, on revenue of $302.30M. The consensus rating from 3 analysts is Buy.
How do analysts rate NPKI stock?
Of 3 analysts covering NPK International, 0 rate it Strong Buy, 3 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from NPKI next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.49, with estimates from $0.47 to $0.50 from 3 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.61, with estimates from $0.58 to $0.65 from 3 analysts.
What revenue do analysts expect from NPK International next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $302.30M, with estimates from $301.00M to $303.90M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $343.75M, with estimates from $341.00M to $348.96M.
How many analysts cover NPKI?
3 analysts rate NPK International stock, and 3 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
NPKI pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors